This can lead to an overestimation of the cancer cell-specific mRNA expression, while in our approach, we only analyzed cancer cell-specific FHOD1 and FMNL1 staining and disregarded the strongly stained immune cells from our scoring results. This evidence concerns the gene FMNL1 and cancer.